Cargando…
Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
Autores principales: | Chang, Vicky C., Khan, Ali A., Huang, Wen-Yi, Katki, Hormuzd A., Purdue, Mark P., Landgren, Ola, Hofmann, Jonathan N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975932/ https://www.ncbi.nlm.nih.gov/pubmed/35365600 http://dx.doi.org/10.1038/s41408-022-00642-4 |
Ejemplares similares
-
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance()
por: Shimanovsky, Alexei, et al.
Publicado: (2016) -
History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study
por: Lindqvist, Ebba K., et al.
Publicado: (2016) -
The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma
por: Yi, Zhigang, et al.
Publicado: (2022) -
It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma
por: Choa, Ruth, et al.
Publicado: (2023) -
Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008)